NASDAQ · Financial Statements
Alterity Therapeutics Limited (ATHE) Financial Statements
$4.70
NASDAQ: ATHE
Market Cap $42.60M
Overview Financials Dividend Alterity Therapeutics Limited most recently reported annual revenue of $5.0M, net profit of $-12.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $4.0M $5.0M $4.0M $4.0M $5.0M Operating Profit $-15.0M $-16.0M $-15.0M $-20.0M $-15.0M Net Profit $-15.0M $-13.0M $-14.0M $-19.0M $-12.0M EPS $-5.40 $-3.18 $-3.42 $-3.12 $-1.14 Op Margin -349.8% -302.6% -373.7% -487.7% -268.0%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $34.0M $41.0M $27.0M $19.0M $46.0M Total Liabilities $3.0M $6.0M $5.0M $5.0M $4.0M Cash $28.0M $35.0M $16.0M $13.0M $33.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-17.0M $-12.0M $-20.0M $-13.0M $-11.0M Investing Cash Flow $0 $0 $0 $0 $-7.0M Financing Cash Flow $-2.0M $-1.0M $0 $-1.0M $-3.0M Net Cash Flow $19.0M $7.0M $-19.0M $-3.0M $21.0M Free Cash Flow $-17.0M $-12.0M $-20.0M $-13.0M $-11.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.10 EV / EBITDA -3.67 FCF Yield -1.92% Quick Ratio 21.98 Interest Coverage 0.00 Return 1Y -8.91% Return 3Y 60.41% Return 5Y -64.93%
Screens featuring this stock